<DOC>
	<DOC>NCT00683384</DOC>
	<brief_summary>The purpose of this study is to collect post-marketing information on the safety of Enbrel in Filipino patients.</brief_summary>
	<brief_title>Study Evaluating the Safety of Enbrel (Etanercept)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Psoriatic</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>All patients from the study center who received or will receive at least one dose of Enbrel according to the approved product indication. Previously discontinued Enbrel therapy due to significant safety concern.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>psoriatic</keyword>
</DOC>